Effects of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Escitalopram Pharmacokinetics: A Cohort Study
Open Access
- 15 June 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 45 (6) , 805-812
Abstract
Background: Changes in the gastrointestinal physiology after bariatric surgery may affect the pharmacokinetics of medications. Data on the impact of different surgical techniques on the pharmacokinetics of commonly prescribed antidepressants such as escitalopram are limited. Methods: This case-only prospective study investigated escitalopram-treated patients who underwent bariatric surgery at hospitals in Central Norway. Escitalopram concentrations were assessed using serial blood samples obtained during a dose interval of 24 hours preoperatively and at 1, 6, and 12 months, postoperatively. The primary outcomes were changes in the area under the time–concentration curve (AUC0-24) with secondary outcomes, including full pharmacokinetic profiling. We performed repeated-measures analysis of variance for the AUC0-24 and secondary outcomes. Results: Escitalopram-treated obese patients who underwent sleeve gastrectomy (n = 5) and Roux-en-Y gastric bypass (n = 4) were included. Compared with preoperative baseline, dose-adjusted AUC0-24 values were within ±20% at all time points, postoperatively in the sleeve gastrectomy and oux-en-Y gastric bypass groups, with the largest changes occurring 1 month postoperatively (+14.5 and +17.2%, respectively). No statistically significant changes in any pharmacokinetic variables over time were reported; however, there was a trend toward increased maximum concentrations after surgery (P = 0.069). Conclusions: Our findings suggest that bariatric surgery has no systematic effect on the pharmacokinetics of escitalopram. However, because of the substantial interindividual variation, therapeutic drug monitoring can be considered to guide postoperative dose adjustments.Keywords
This publication has 36 references indexed in Scilit:
- Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and SertralineTherapeutic Drug Monitoring, 2015
- Gastrointestinal changes after bariatric surgeryDiabetes & Metabolism, 2014
- A Comparison of Duloxetine Plasma Levels in Postbariatric Surgery Patients Versus Matched Nonsurgical Control SubjectsJournal of Clinical Psychopharmacology, 2013
- All Bariatric Surgeries Are Not Created Equal: Insights from Mechanistic ComparisonsEndocrine Reviews, 2012
- The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake InhibitorsAmerican Journal of Psychiatry, 2012
- CYP2C19genotype predicts steady state escitalopram concentration in GENDEPJournal of Psychopharmacology, 2011
- Cytochrome P450-mediated metabolism in the human gut wallJournal of Pharmacy and Pharmacology, 2009
- Cytochrome P450-mediated metabolism in the human gut wallJournal of Pharmacy and Pharmacology, 2009
- The Clinical Pharmacokinetics of EscitalopramClinical Pharmacokinetics, 2007
- Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndromeInternational Journal of Obesity, 2004